Eczema Free Forever™ Eczema Free Forever™

Risk Factors for Melanoma and Genetic Testing

While one German study has shown that population-wide screening for melanoma could dramatically reduce mortality, potential problems with the strategy include cost due to the overall rarity of the disease, patient compliance, and difficulties identifying patients likely to develop melanoma. Therefore, scientists are developing prediction models to identify those at high risk for melanoma, which can include genetic factors. Learn more
Modern medicine – American Academy of Dermatology

Moving toward personalized medicine for melanoma

New research indicates that cutaneous melanoma is the most mutation-driven form of all cancers. While research has determined that there is more than one form of cutaneous melanoma, forms with more mutations may respond better to immunotherapies that have been approved by the Federal Drug Administration (FDA) since 2011. Learn more
Modern medicine – American Academy of Dermatology